Your Health, We Care
Osimertinib is an efficient and safe EGFR-TKI inhibitor, providing a new treatment option for EGFR mutant non-small cell lung cancer patients.
Osimertinib has been approved in multiple countries and regions around the world, including the United States, European Union, Japan, and China, for the second-line treatment of advanced non-small cell lung cancer patients who have developed EGFR T790M resistance mutations after EGFR-TKI treatment.
Explore osimertinib and its role in the treatment of lung cancer, as well as its side effect management.What are the indications for osimertinibTo understand osimertinib in depth, ···【more】
Article source：Lucius LaosRelease date：2025-02-28Recommended：85
Explore the price of osimertinib and its role in treatment, as well as learn how to better manage the associated costs.Is osimertinib expensive? How much is a box?Osimertinib has a···【more】
Article source：Lucius LaosRelease date：2025-02-28Recommended：86
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
